Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 trial: A phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma

被引：13
|
作者：
Venook, Alan P.
Blanke, Charles D.
Niedzwiecki, Donna
Lenz, Heinz-Josef
Taylor, John R.
Hollis, Donna R.
Sutherland, Susan
Goldberg, Richard M.
机构：
[1] Univ Calif San Francisco, Dept Clin Med, San Francisco, CA 94115 USA
[2] Canc & Leukemia Grp B, Chicago, IL USA
[3] SW Oncol Grp, San Antonio, TX USA
[4] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[5] Duke Univ, Durham, NC USA
[6] Univ So Calif, Los Angeles, CA USA
[7] Univ N Carolina, Chapel Hill, NC USA
来源：
CLINICAL COLORECTAL CANCER | 2007年 / 6卷 / 07期
关键词：
bevacizumab; cetuximab; FOLFIRI; FOLFOX;
D O I：
10.3816/CCC.2007.n.021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：536 / 538
页数：3
相关论文
共 50 条
  • [31] Phase II trial of topotecan in advanced breast cancer - A Cancer and Leukemia Group B study
    Levine, EG
    Cirrincione, CT
    Szatrowski, TP
    Canellos, G
    Norton, L
    Henderson, IC
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (03): : 218 - 222
  • [32] A PHASE-II TRIAL OF PIROXANTRONE IN ADENOCARCINOMA OF THE PANCREAS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    JENKINS, TR
    TANGEN, C
    MACDONALD, JS
    WEISS, G
    CHAPMAN, R
    HANTEL, A
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (04) : 329 - 331
  • [33] PHASE-II TRIAL OF MENOGARIL IN ADENOCARCINOMA OF THE PANCREAS - A SOUTHWEST ONCOLOGY GROUP-STUDY
    BROWN, TD
    GOODMAN, PJ
    FLEMING, TR
    BAKER, LH
    MACDONALD, JS
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (01) : 77 - 78
  • [34] A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: A Gynecologic Oncology Group study
    Ball, HG
    Blessing, JA
    Lentz, SS
    Mutch, DG
    GYNECOLOGIC ONCOLOGY, 1996, 62 (02) : 278 - 281
  • [35] Phase II trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study
    Rothenberg, ML
    Benedetti, JK
    Macdonald, JS
    Seay, TE
    Neubauer, MA
    George, CS
    Tanaka, MS
    Giguere, JK
    Pruitt, BT
    Abbruzzese, JL
    ANNALS OF ONCOLOGY, 2002, 13 (10) : 1576 - 1582
  • [36] A PHASE-II TRIAL OF RECOMBINANT TUMOR-NECROSIS-FACTOR IN PATIENTS WITH METASTATIC COLORECTAL ADENOCARCINOMA - A SOUTHWEST ONCOLOGY GROUP-STUDY
    WHITEHEAD, RP
    FLEMING, T
    MACDONALD, JS
    GOODMAN, PJ
    NEEFE, J
    BRAUN, TJ
    SWINNEN, LJ
    HERSH, EM
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1990, 9 (06): : 588 - 591
  • [37] PHASE-II TRIAL OF DIDEMNIN-B IN ADVANCED EPITHELIAL OVARIAN-CANCER - A SOUTHWEST ONCOLOGY GROUP-STUDY
    CAIN, JM
    LIU, PY
    ALBERTS, DE
    GALLION, HH
    LAUFMAN, L
    OSULLIVAN, J
    WEISS, G
    BICKERS, JN
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (01) : 23 - 24
  • [38] A phase II trial of piroxantrone in endometrial cancer: Southwest Oncology Group study 8918
    Malviya, VK
    Liu, PY
    Goldberg, DA
    Hantel, A
    OToole, RV
    Roach, RW
    Conrad, ME
    Alberts, DS
    ANTI-CANCER DRUGS, 1996, 7 (05) : 527 - 530
  • [39] Phase II trial of vinorelbine for relapsed ovarian cancer: a Southwest Oncology Group study
    Rothenberg, ML
    Liu, PY
    Wilczynski, S
    Nahhas, WA
    Winakur, GL
    Jiang, CS
    Moinpour, CM
    Lyons, B
    Weiss, GR
    Essell, JH
    Smith, HO
    Markman, M
    Alberts, DS
    GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 506 - 512
  • [40] PHASE-II TRIAL OF MITOXANTRONE IN ADVANCED SARCOMAS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    BULL, FE
    VONHOFF, DD
    BALCERZAK, SP
    STEPHENS, RL
    PANETTIERE, FJ
    CANCER TREATMENT REPORTS, 1985, 69 (02): : 231 - 233
12345